Stay updated on Imsidolimab in Generalized Pustular Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Imsidolimab in Generalized Pustular Psoriasis Clinical Trial page.

Latest updates to the Imsidolimab in Generalized Pustular Psoriasis Clinical Trial page
- Check7 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing Revision: v3.5.3. This update reflects a version label change to the page template/display system rather than changes to the study data.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe footer release/version indicator for the ClinicalTrials.gov page was updated from “Revision: v3.5.2” to “Revision: v3.5.3.” This reflects an interface/backend update rather than a change to the study record content.SummaryDifference0.1%

- Check35 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.1%

- Check78 days agoChange DetectedFooter revision indicator updated from Revision: v3.4.2 to Revision: v3.4.3.SummaryDifference0.1%

- Check85 days agoChange DetectedAdded Generalized pustular psoriasis as a condition reference and introduced a Resources section with a link to the Genetic and Rare Diseases Information Center.SummaryDifference0.2%

Stay in the know with updates to Imsidolimab in Generalized Pustular Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Imsidolimab in Generalized Pustular Psoriasis Clinical Trial page.